Sullivan Christopher Ryan

EDGAR CIK 0001810417

Avalo Therapeutics, Inc. - AVTX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
4
($493,183)
-32,874 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
04/30/2026
10b5-1
05/01/2026
Sell
-8,457 @ $13.23
 ($111,853) 423 (-95.24%) Direct
04/29/2026
10b5-1
05/01/2026
Sell
-8,458 @ $13.09
 ($110,736) 8,880 (-48.78%) Direct
04/02/2026
10b5-1
04/03/2026
Sell
-7,980 @ $17.15
 ($136,823) 17,338 (-31.52%) Direct
04/01/2026
10b5-1
04/03/2026
Sell
-7,979 @ $16.77
 ($133,770) 25,318 (-23.96%) Direct